Exploration of Pharmaceutical Cocrystals of Zaltoprofen: Development, Physicochemical Characterization, and Enhancement of Solubility and Dissolution Behavior
Abstract
Biopharmaceutics Classification System (BCS) Class II drugs are characterized by low aqueous solubility, which can limit dissolution and oral absorption. Zaltoprofen is a non-steroidal anti-inflammatory drug with a hydrophobic structure and limited aqueous solubility. Pharmaceutical cocrystallization offers a solid-state strategy for modifying lattice packing and physicochemical properties without altering the covalent structure of the active pharmaceutical ingredient. This review summarizes principles of cocrystal design, coformer selection, preparation methods, solid-state characterization, and the effects of cocrystallization on solubility and dissolution behavior, with particular emphasis on zaltoprofen. Solution-based crystallization, mechanochemical approaches such as liquid-assisted grinding, and emerging continuous-processing approaches including hot-melt extrusion are discussed. The review also emphasizes that improved dissolution is not guaranteed and may be limited by lattice stability, supersaturation loss, or solution-mediated phase transformation. Translational success will therefore depend on rational coformer selection, robust solid-state characterization, scalable manufacturing, and appropriate in vitro and in vivo validation. The review further considers the use of coformers such as nicotinamide and 4,4′-bipyridine, while emphasizing that dissolution enhancement is system-dependent and must be demonstrated experimentally.
Keywords: Zaltoprofen, Pharmaceutical cocrystals, BCS class II drug , Solubility Enhancement
Keywords:
Zaltoprofen, Pharmaceutical cocrystals, BCS class II drug , Solubility EnhancementDOI
https://doi.org/10.22270/jddt.v16i9.7986References
1. Bakrey H, et al. Innovative strategies and advances in drug delivery systems to address poor solubility: a comprehensive review. Curr Drug Targets. 2025. https://doi.org/10.2174/0113894501375776250713110838 PMid:40696549
2. Aniceto N, Freitas A, Ghafourian T. Modeling ADME/Tox for drug discovery in the age of data. In: Springer Handbook of Chem- and Bioinformatics. Springer; 2026. p. 387-415. https://doi.org/10.1007/978-3-031-81728-1_18
3. Sallam NA, et al. A review on environmental impacts and advanced removal strategies of non-steroidal anti-inflammatory drugs. Int J Environ Res. 2025;19(6):1-27. https://doi.org/10.1007/s41742-025-00907-3
4. Hegishte Y, Joyce P, Prestidge C, Bremmell K. Overcoming the oral delivery challenges of venetoclax: advancing a clinically improved Bcl-2 inhibitor. Drug Deliv Transl Res. 2026. p. 1-21. https://doi.org/10.1007/s13346-026-02093-x PMid:41806106
5. Mahesha BS, Sheeba FR, Deepak HK. A comprehensive review of green approaches to drug solubility enhancement. Drug Dev Ind Pharm. 2025;51(7):659-669. https://doi.org/10.1080/03639045.2025.2496940 PMid:40262280
6. Giri S, Irfan Z, Haque SE, Ganguly SC, Das S. Bioactive-based nanotherapeutics in pain management: a revolutionary approach. Bioact Nanotherapeutics. 2025. p. 619-661. https://doi.org/10.1002/9781394287345.ch19
7. Allgood JE, Whitney L, Goodwin J, Chong BSH, Brooks A, Pullan J. The role of pain medications in modulating peripheral nerve injury recovery. J Clin Pharmacol. 2025;65(4):411-423. https://doi.org/10.1002/jcph.6156 PMid:39492597
8. Biswas UK, Bose A, Ghosh B, Sharma S. An insight into chemically modified chitosan and their biological, pharmaceutical, and medical applications: a review. Int J Biol Macromol. 2025;303:140612. https://doi.org/10.1016/j.ijbiomac.2025.140612 PMid:39909251
9. Moriano P, Hespeler SC, Li M, Mahbub M. Adaptive anomaly detection for identifying attacks in cyber-physical systems: a systematic literature review. Artif Intell Rev. 2025;58(9):283. https://doi.org/10.1007/s10462-025-11292-w
10. Agostini SBN, Borges BA, de Araújo MB, Bonfilio R. Growing interest in pharmaceutical cocrystals: a comprehensive review of applications and trends. ChemistrySelect. 2025;10(30). https://doi.org/10.1002/slct.202500831
11. Rao RP, et al. Advances in pharmaceutical cocrystals and nano-cocrystals: strategies for enhancing solubility and translating to clinical use. AAPS PharmSciTech. 2025;26(8):233. https://doi.org/10.1208/s12249-025-03228-y PMid:41044456
12. Jha R, Patel S, Sekhani A, Parmar HA, Desai N, Shah P. Rational design of amiodarone co-crystals: a synergistic strategy combining computational prediction, precipitation-inhibiting polymers, and formulation optimisation. AAPS PharmSciTech. 2026;27(3):123. https://doi.org/10.1208/s12249-026-03361-2 PMid:41775983
13. Drapińska P, Skulmowska-Polok K, Chałupka J, Sikora A. Sustained-release oral delivery of NSAIDs and acetaminophen: advances and recent formulation strategies-a systematic review. Pharmaceutics. 2025;17(10):1264. https://doi.org/10.3390/pharmaceutics17101264 PMid:41155901 PMCid:PMC12567289
14. Das M, Habibullah S, Das T, Mallick S. Pharmaceutical cocrystals for solubility enhancement of drugs. In: Cocrystals: Pharmaceutical Science, Design to Applications. 2025. p. 257-292. https://doi.org/10.1002/9781394302505.ch9
15. Yang Y, Lu J. Cocrystal technology in the screening of pharmaceutical solid forms and chiral resolution of drugs: a review. Cryst Res Technol. 2025;60(9). https://doi.org/10.1002/crat.70013
16. Pandey V, Kaundal RS, Pandey T. Exploring green chemistry in pharmaceutical crystallization: the role of deep eutectic solvents in enhancing drug performance and sustainability. Chem Africa. 2025;8(9):4111-4126. https://doi.org/10.1007/s42250-025-01471-1
17. Singh H, et al. Design and structural characteristics of pharmaceutical cocrystals. In: Cocrystals: Pharmaceutical Science, Design to Applications. 2025. p. 29-53. https://doi.org/10.1002/9781394302505.ch2
18. Araújo CF, Abranches DO, Coutinho JAP, Vaz PD, Ribeiro-Claro P, Nolasco MM. Good vibrations: understanding deep eutectic solvents through the lens of vibrational spectroscopy. Appl Spectrosc Rev. 2025;60(2):137-192. https://doi.org/10.1080/05704928.2024.2390962
19. Chougule S, Manchanda K, Sood M, Bansal AK, Bharatam PV. Pharmacoinformatics in drug-excipient interactions. Mol Pharm. 2025;22(12):7210-7238. https://doi.org/10.1021/acs.molpharmaceut.5c00801 PMid:41144649
20. Wang J, Zhang Q, Zhao J, Shi H, Zhang H, Yang P. Aggregation-induced synergy in photocatalysis: enhanced light harvesting and efficient charge separation. ChemSusChem. 2026;19(5). https://doi.org/10.1002/cssc.202502706 PMid:41795881
21. Grabowski S, et al. The whole is greater than the sum of its parts: binary and ternary 5-fluorouracil co-crystals with enhanced selectivity towards metastatic cancer cells. Chem Commun. 2025;61(86):16770-16773. https://doi.org/10.1039/D5CC01707F PMid:40988541
22. Sreedevi A, Raj EA, Sreedhar D, Ligade VS. Exploring the challenges faced by generic version of complex drugs: a scoping review. Syst Rev. 2025;14(1):183. https://doi.org/10.1186/s13643-025-02931-y PMid:41024286 PMCid:PMC12482112
23. Kamble N, Chavan R, Bhosale N, Khade P, Jagtap P. Pharmaceutical cocrystals: mechanochemical and computational methods for supramolecular engineering to improve the solubility of BCS class II/IV APIs and herbal actives. World. 2026;5(3).
24. Lee C, Gossage ZT, Kumakura S, Komaba S. Comparative insights and overlooked factors of interphase chemistry in alkali metal-ion batteries. Adv Energy Mater. 2026. https://doi.org/10.1002/aenm.202506154
25. Liang X, et al. Recent developments on co-crystal polymorphs: from formation to prediction. CrystEngComm. 2025;27(39):6415-6432. https://doi.org/10.1039/D5CE00652J
26. Yewale S, Alavala RR, Gokhale K. Computational tools for solubility prediction. In: Applications of Computational Tools in Drug Design and Development. Springer; 2025. p. 343-386. https://doi.org/10.1007/978-981-96-4154-3_11 PMid:28118817
27. Jayant V, Kumar R, Tyagi P, Yusuf M. Grinding and milling (mechanochemical) methods: an excellent greener approach to develop sustainable materials. In: Green Chemistry. Elsevier; 2025. p. 133-168. https://doi.org/10.1016/B978-0-443-21990-0.00007-9
28. Fratello V, Ko SW. Top-seeded solution growth of lead zirconate titanate single crystals from a high temperature solution. J Cryst Growth. 2025;657:128109. https://doi.org/10.1016/j.jcrysgro.2025.128109
29. Kar A, Prasad Manu KR, Giri L, Dandela R. Beyond the covalent bond-the world of co-crystals to tune the physicochemical properties of materials. Adv Sustain Syst. 2025;9(8). https://doi.org/10.1002/adsu.202500034
30. Ye Q, Wang S, Zhang Z. ML-driven pharmaceutical cocrystal technology: advances in screening, property prediction and applications. AAPS PharmSciTech. 2026;27(1):63. https://doi.org/10.1208/s12249-025-03266-6 PMid:41507647
31. Sharma RG, Vankar SD, Sharma MG. The cocrystal advantage: overcoming polymorph patent barriers in generic drug development. Mol Divers. 2025. p. 1-23. https://doi.org/10.1007/s11030-025-11375-4 PMid:41212466
32. Petrick TL, Hubmann A, Braun DE. Caprolactam cocrystals: bridging virtual screening to experimental solid-state forms and stability. Cryst Growth Des. 2025;25(8):2657-2673. https://doi.org/10.1021/acs.cgd.5c00156
33. Li X, Ren L, Zheng X, Poudel B, Wang K, Qian J. Multiscale coupling between macroscopic mechanics and atomic assembly (MM-AA) of soft-lattice halide perovskites: special collection: 2025 emerging investigators. Aggregate. 2025;6(11). https://doi.org/10.1002/agt2.70170
34. Enguita AMA, et al. Insights into pharmaceutical co-crystallization using coherent Raman microscopy. J Pharm Sci. 2025;114(1):626-636. https://doi.org/10.1016/j.xphs.2024.10.054 PMid:39491673
35. Zheng Y, Yang J, Liu Z, Qiao Z. Multi-component crystalline mesoporous materials: synthesis principle and application. Adv Mater. 2025;37(43). https://doi.org/10.1002/adma.202510911 PMid:40847914
36. Saripilli R, Sharma DK. A comprehensive review of solubility enhancement techniques for poorly soluble drugs. J Solution Chem. 2025. p. 1-27. https://doi.org/10.1007/s10953-025-01502-y
37. Quodbach J, Preis E, Karkossa F, Winck J, Finke JH, Steiner D. Novel strategies for the formulation of poorly water-soluble drug substances by different physical modification strategies with a focus on peroral applications. Pharmaceuticals. 2025;18(8):1089. https://doi.org/10.3390/ph18081089 PMid:40872482 PMCid:PMC12388907
38. Wu Z, Xie J, Zhang X, Liang Z. On refining exciton dissociation and charge transport of nonfullerene organic photovoltaics: from star-shaped acceptors to molecular doping. Adv Mater. 2025. https://doi.org/10.1002/adma.202509697 PMid:40923524
39. Chatziadi A, Neubergerová K, Balaga VKR, Trunov D, Šoóš M. Selective formation of coamorphous systems with enzalutamide: benzene rings as key structural features. Eur J Pharm Sci. 2025:107281. https://doi.org/10.1016/j.ejps.2025.107281 PMid:40976375
40. Zou F, et al. Dual-pathway solvate transformation: synthesis of a more stable temozolomide-ferulic acid cocrystal hydrate. J Mol Struct. 2026:145585. https://doi.org/10.1016/j.molstruc.2026.145585
41. Patulski P, Berenguer-Murcia Á, Cazorla-Amorós D. Mechanochemistry-driven synthesis of Cu/P25/g-C3N4 photocatalysts for sustainable CO2 reduction. J Environ Chem Eng. 2025:119809. https://doi.org/10.2139/ssrn.5374709
42. Halagali P, Sharannavar BR. The hot melt extrusion (HME) in pharmaceutical technology: a comprehensive review. IJSAT Int J Sci Technol. 2025;16(2). https://doi.org/10.71097/IJSAT.v16.i2.4934
43. Alai R, Mestry S, Darsan Mohanty J, Mhaske ST. Innovating PVC plasticization: performance and potential of a lauric acid ester-amide plasticizer. Iran Polym J. 2025;34(8):1151-1165. https://doi.org/10.1007/s13726-024-01435-1
44. Thakur N, et al. Preparation techniques of pharmaceutical cocrystals. In: Cocrystals: Pharmaceutical Science, Design to Applications. 2025. p. 93-120. https://doi.org/10.1002/9781394302505.ch4
45. Ling W, et al. From lab to plant: technical barriers in scaling up LiMnyFe1-yPO4 production-a process engineering perspective. Adv Energy Mater. 2025;15(36):2502720. https://doi.org/10.1002/aenm.202502720
46. Toma FTZ, Rahman MS, Maria KH. A review of recent advances in ZnO nanostructured thin films by various deposition techniques. Discov Mater. 2025;5(1):60. https://doi.org/10.1007/s43939-025-00201-1
47. Bansal AK, Kumar D. Solid-state pharmaceutics research in India: present and future. Mol Pharm. 2025;22(7):3523-3529. https://doi.org/10.1021/acs.molpharmaceut.5c00534 PMid:40442046
48. Ferreira Monteiro M. The conversion of poorly soluble drugs into multicomponent systems with low melting points as an approach to improve oral formulations [thesis]. Dublin: Trinity College Dublin, School of Pharmacy and Pharmaceutical Sciences; 2025.
49. Alayadan P, et al. Development, in vitro and in vivo evaluation of film forming solutions for transdermal drug delivery of zaltoprofen. J Biomater Sci Polym Ed. 2025;36(9):1265-1288. https://doi.org/10.1080/09205063.2024.2443332 PMid:39711234
50. Wang C, Xu J, Deng F. Intermolecular interactions in zeolite catalysis: insights from solid-state NMR spectroscopy. Acc Chem Res. 2025;58(21):3328-3340. https://doi.org/10.1021/acs.accounts.5c00652 PMid:41138197
51. Bhoumik MK. The role of drug-drug co-amorphous systems in sustained release and combination therapy for insoluble small molecules. Int J Pharmacy Pharm Sci 2025; 7(1): 385-391. https://doi.org/10.33545/26647222.2025.v7.i1e.240
52. Bhoumik MK. A quality-by-design approach to amorphous solid dispersion development integrating process analytics for enhanced solubility and stability. The Pharma Innov J 2023; 12(6): 5233-5240. https://doi.org/10.22271/tpi.2023.v12.i6bh.26303
53. Kumara K, Ghantasala VS. Structural and computational insights into ternary cocrystals of succinimide with 3-nitrophthalic acid and urea. J Mol Struct. 2026:145400. https://doi.org/10.1016/j.molstruc.2026.145400
54. Bandyopadhyay S, Uçar Ş. Nucleation and growth of nanoparticles. In: Engineering Nanoparticles for Biomedical Applications: From Theory to Experiments and Modeling. Wiley-VCH; 2025/2026. p. 3-21. https://doi.org/10.1002/9783527844791.ch1
55. Janning JA, et al. Buspirone hydrochloride polymorphism: stability, solubility, flow properties, and manufacturing implications. Adv Pharmacol Pharm Sci. 2025;2025(1):1941957. https://doi.org/10.1155/adpp/1941957 PMid:41113553 PMCid:PMC12531592
56. Suresh K, Mehta T, Thakrar V, Sharma RG. Innovative strategies in generic drug development: the role of polymorph, amorphous, pseudopolymorph, and cocrystal solid forms. Cryst Growth Des. 2025;25(4):1282-1292. https://doi.org/10.1021/acs.cgd.4c01558
57. Kar A, Giri L, Patra TN, Dandela R. Recent advances in the creation of supramolecular assemblies by polymer-aided co-crystallization approach. ChemistrySelect. 2025;10(46). https://doi.org/10.1002/slct.202505073
58. Chen S, et al. Carbazole-based bolaamphiphiles with complex self-assembly for perovskite solar cells application. Small. 2025;21(36):2504190. https://doi.org/10.1002/smll.202504190 PMid:40641326
59. Dhaval M, et al. Pharmaceutical salts: comprehensive insights from fundamental chemistry to FDA approvals (2019-2023). AAPS PharmSciTech. 2025;26(1):36. https://doi.org/10.1208/s12249-024-03020-4 PMid:39821716
60. Jin H, Ali S, Pan J, Jin Y, Sheng L. From molecular interactions to foam dynamics: how ionic strength and pH shape egg white protein performance at the air-water interface. Food Hydrocoll. 2025;162:110991. https://doi.org/10.1016/j.foodhyd.2024.110991
61. Hayat S, et al. Development and evaluation of carbamazepine-succinic acid co-crystal-based orally disintegrating tablets: a novel approach for enhanced solubility and rapid drug release. J Pharm Innov. 2026;21(3):236. https://doi.org/10.1007/s12247-026-10446-9
62. Edumujeze D, Thomas K, Mauge F, Devouge-Boyer C, Fournier-Salaun MC, Leveneur S. Towards sustainable furfural production: investigating solvent effects, reaction kinetics, process simulation, and energy assessment. Chem Eng J. 2025;519:165126. https://doi.org/10.1016/j.cej.2025.165126
63. Shi Y, Wang X, Xiao W, Li J, Wang D. Development of water-soluble nicotinamide coenzyme biomimetics for improved catalytic efficiency. ChemistrySelect. 2025;10(16). https://doi.org/10.1002/slct.202501957
64. Pagare D, Sirsam R, Devare S, Patil P, Patil J. Recent advances in pharmaceutical cocrystal design: leveraging in-silico technologies for enhanced drug development. Crystallogr Rev. 2025. p. 1-53. https://doi.org/10.1080/0889311X.2025.2550764
65. Chavan DD, Thorat VM, Shete AS, Bhosale RR. Solvent assisted cocrystallization of itraconazole: solid-state properties, dissolution, stability, antifungal potential, and solution-mediated phase transformation studies. Rasayan J Chem. 2025;18(2). https://doi.org/10.31788/RJC.2025.1829256
66. Balaga VKR, Chatziadi A, Ridvan L, Šoóš M. Structurally similar, functionally different: impact of coformer positional isomerism on co-amorphous enzalutamide. Eur J Pharm Sci. 2025:107425. https://doi.org/10.1016/j.ejps.2025.107425 PMid:41482103
67. Song Y, Ding Y, Su J, Li J, Ji Y. Unlocking the potential of machine learning in co-crystal prediction by a novel approach integrating molecular thermodynamics. Angew Chem Int Ed. 2025;64(21). https://doi.org/10.1002/anie.202502410 PMid:40072272
68. Newman LM, Kavanagh ON, Machado TC. DSPindex guides dose selection to extend drug supersaturation lifetime during cocrystal dissolution. Int J Pharm. 2025;671:125298. https://doi.org/10.1016/j.ijpharm.2025.125298 PMid:39892676
69. Bhoumik MK. Development and evaluation of amorphous solid dispersions to enhance solubility of poorly water- soluble drugs using hot-melt extrusion and spray- drying techniques. The Pharma Innov J 2024; 13(7): 222-230. https://doi.org/10.22271/tpi.2024.v13.i7c.26304
70. Garg U, Agrawal I, Azim Y. Investigating crystal structure, chemical reactivity, and non-covalent interactions in the 1-naphthalene acetic acid-urea cocrystal by systematic computational methods. J Mol Struct. 2025;1325:140986. https://doi.org/10.1016/j.molstruc.2024.140986
71. Fan R, Chen A, Yu Y, Cai T, Guo M. Solution-mediated phase transformation of cocrystals at the solid-liquid interface: relationships between the supersaturation generation rate and transformation pathway. Int J Pharm. 2025;668:124969. https://doi.org/10.1016/j.ijpharm.2024.124969 PMid:39566698
72. Tripathi D, Gupta VK, Pandey P, Rajinikanth PS. Metabolic insights into drug absorption: unveiling piperine’s transformative bioenhancing potential. Pharm Res. 2025;42(10):1857-1891. https://doi.org/10.1007/s11095-025-03920-5 PMid:41053306
73. Ghosh A. Mechanistic insights into amorphous solid dispersions: bridging theory and practice in drug delivery. Pharm Res. 2025;42(1):1-23. https://doi.org/10.1007/s11095-024-03808-w PMid:39849216
74. Tran TP, Tran NP, Park JS. Pharmacokinetic modeling in drug delivery system. J Pharm Investig. 2025. p. 1-23. https://doi.org/10.1007/s40005-025-00792-0
75. Ishikawa M, Tomoshige S, Sato S. Challenges of Aufheben to promote druglikeness: chemical modification strategies to improve aqueous solubility and permeability. J Med Chem. 2025;68(20):20859-20902. https://doi.org/10.1021/acs.jmedchem.5c00287 PMid:41061162 PMCid:PMC12557401
76. Belov KV, Khodov IA. Conformational landscape, polymorphism, and solid forms design of bicalutamide: a review. Molecules. 2025;30(18):3793. https://doi.org/10.3390/molecules30183793 PMid:41011684 PMCid:PMC12472616
77. Miles DL. Water-Rock Interaction (WRI-6): Proceedings of the 6th International Symposium (WRI-6), Malvern, UK, 3-6 August 1989. CRC Press; 2026. https://doi.org/10.1201/9781003763505
78. Moroni AB, Bottoso T, Lionello DF, Vega DR, Kaufman TS, Calvo NL. Preparation, characterization, and water-assisted phase transformation of sulfuric and sulfonic salts of sulfamethoxazole-hydrogen sulfate, mesylate, and tosylate. Cryst Growth Des. 2025;25(7):2172-2185. https://doi.org/10.1021/acs.cgd.5c00130
79. Neustock A, Kristina L. Clarithromycin nanocrystals for high-dose inhalation. 2026.
80. Nithyanantham D, Nair A, Nayak UY. Leveraging artificial intelligence for advancements in liquid dosage formulations in the pharmaceutical industry. Ther Innov Regul Sci. 2025;59(5):1004-1031. https://doi.org/10.1007/s43441-025-00823-w PMid:40560305 PMCid:PMC12446089
81. Bhoumik MK. The role of advanced characterization in optimizing nano carrier formulations for oral delivery of poorly soluble small molecules. Int J Pharm PharmSci 2024; 6(1): 65-72. https://doi.org/10.33545/26647222.2024.v6.i1a.241
82. Adorjan K, Herdegen T, Lang U, Luciani P, Nicolussi S, Tam J. Jürg Gertsch Institute of Biochemistry and Molecular Medicine, University of Bern; Rudolf Brenneisen Swiss Academy of Pharmaceutical Sciences, SAPhW.
Published
Abstract Display: 0 
PDF Downloads: 0 PDF Downloads: 0 How to Cite
Issue
Section
Copyright (c) 2026 Rajan Kumar , Sakshi Tomar , Ram Babu Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.